Dementia is a globally widespread brain disease, which afflicts someone new every 3 seconds. The number of people suffering from dementia exceeds 44 million, with the number probably reaching almost 76 million by 2030 and potentially doubling by 2050. The most common cause of dementia is Alzheimer’s disease, but the reasons behind its outbreak are not entirely clear, nor can current medicine completely heal it. The team’s research is aimed towards studying the early metabolic and structural biomarkers of Alzheimer’s disease and other forms of dementia.

The research is currently based on the unique longitudinal Czech Brain Aging Study, which recruited patients who lodged memory complaints from 2011–2017. The team is also researching neurochemical and genetic biomarkers in the blood and the cerebrospinal liquid or structural, metabolic and functional biomarkers of people undergoing magnetic resonance imaging.

Go to top